The Use of Chimpanzees in NIH-Supported Research, 6873-6874 [2016-02554]

Download as PDF Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors for Basic Sciences, National Cancer Institute. Date: March 7, 2016. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, 31 Center Drive, Building 31, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. Contact Person: Mehrdad Tondravi, Ph.D., Chief, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 3W302, Rockville, MD 20850, 240–276–5660, tondravim@mail.nih.gov. Name of Committee: Board of Scientific Counselors for Clinical Sciences and Epidemiology, National Cancer Institute. Date: March 8, 2016. Time: 8:30 a.m. to 4:30 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, 31 Center Drive, Building 31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. Contact Person: Brian E. Wojcik, Ph.D., Executive Secretary, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 3W414, Rockville, MD 20850, 240–276–5660, wojcikb@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 4, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–02534 Filed 2–8–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and VerDate Sep<11>2014 17:54 Feb 08, 2016 Jkt 238001 the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; NIAAA Member Conflict Applications—Neurosciences. Date: March 11, 2016. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health— NIAAA, 5635 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5365 Fishers Lane, Room 2085, Rockville, MD 20852, (301) 451–2067, srinivar@ mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; NIAAA Member Conflict Applications—Clinical, Behavioral and Epidemiological Studies. Date: March 14, 2016. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health— NIAAA, 5635 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5365 Fishers Lane, Room 2085, Rockville, MD 20852, (301) 451–2067, srinivar@ mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; NIAAA Member Conflict Applications—Biomedical Sciences. Date: March 16, 2016. Time: 2:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health— NIAAA, 5635 Fishers Lane, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Ranga Srinivas, Ph.D., Chief, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5365 Fishers Lane, Room 2085, Rockville, MD 20852, (301) 451–2067, srinivar@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS) PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 6873 Dated: February 4, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–02539 Filed 2–8–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The Use of Chimpanzees in NIHSupported Research This notice provides information on the National Institutes of Health’s (NIH) reassessment of the need to maintain a colony of 50 chimpanzees for future research and decision to no longer maintain a chimpanzee colony for research. This notice also provides information on conforming updates and procedures related to this action. FOR FURTHER INFORMATION CONTACT: The Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health at dpcpsi@ od.nih.gov. SUMMARY: On November 18, 2015, the NIH announced it will no longer maintain a colony of 50 chimpanzees for future research and that all NIH-owned chimpanzees that reside outside the federal sanctuary system operated by Chimp Haven, Keithville, Louisiana, are eligible for retirement. Relocation of the chimpanzees to the federal sanctuary system will be conducted as space is available and on a timescale that will allow for optimal transition of each individual chimpanzee with careful consideration of their welfare, including their health and social grouping. See the NIH Director’s statement at https://www. nih.gov/about-nih/who-we-are/nihdirector/statements/nih-will-no-longersupport-biomedical-researchchimpanzees. Consistent with this decision, the NIH is limiting its future support for research using chimpanzees to that which would be permissible in the federal sanctuary system under the Chimpanzee Health Improvement, Maintenance and Protection (CHIMP) Act and the implementing regulations at 42 CFR part 9. Such research must either be noninvasive behavioral studies or medical studies based on information collected during the course of normal veterinary care that is provided for the benefit of the chimpanzee, provided that any such study involves minimal physical and mental harm, pain, distress, and disturbance to the SUPPLEMENTARY INFORMATION: E:\FR\FM\09FEN1.SGM 09FEN1 mstockstill on DSK4VPTVN1PROD with NOTICES 6874 Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices chimpanzee and the social group in which the chimpanzee lives. Specifically, permissible research, as described in the ‘‘Standards of Care for Chimpanzees Held in the Federally Supported Chimpanzee Sanctuary System’’ at 42 CFR part 9, includes: • Visual observation; • Behavioral studies designed to improve the establishment and maintenance of social groups. These activities may cause stress as a result of novel interactions between chimpanzees and caregivers, but they are not considered invasive as long as they are intended to maximize the well-being of the chimpanzees; • Medical examinations as deemed necessary to oversee the health of the chimpanzees, in the least invasive manner possible. Collection of samples routinely obtained during a physical examination for processing during this time is also considered noninvasive since a separate event is not required; • Administration and evaluation of environmental enrichment used to promote the psychological well-being of the chimpanzees; and • Actions taken to provide essential medical treatment to an individual chimpanzee exhibiting symptoms of illness. This applies only to serious illness that cannot be treated while the chimpanzee remains within the colony. • Observational studies and collection of biomaterial in the wild without interfering with the chimpanzee is also permitted. These decisions apply to all new or competing renewals of grant applications, contract proposals, intramural protocols, and 3rd party projects. The NIH may issue future guidance about the permissible noninvasive research involving chimpanzees. Researchers are encouraged to contact their program officers for additional information or the Division of Program Coordination, Planning, and Strategic Initiatives at dpcpsi@od.nih.gov. The NIH’s decision to allow the support of noninvasive research involving the use of chimpanzees, as described in this notice, does not affect requirements for investigators and/or their institutions to obtain permits from the U.S. Fish and Wildlife Service, if applicable, nor does it affect the responsibility to meet all applicable veterinary, colony, and husbandry obligations. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Human Genome Research Institute; Notice of Closed Meetings Submission for OMB Review; 30-Day Comment Request; Application Forms for the NIDA Summer Research Internship Program Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special Emphasis Panel, KOMP2 (Knockout Mouse Phenotyping Program). Date: March 3, 2016 Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: NHGRI, 5635FL, NHGRI Twinbrook Library, Fishers Lane, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Lita Proctor, Ph.D., Extramural Research Programs Staff, Program Director, Human Microbiome Project, National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20892, 301 496–4550, proctorlm@ mail.nih.gov. Name of Committee: National Human Genome Research Institute Special Emphasis Panel, Sequencing Technology Special Emphasis Panel. Date: March 24, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Marriott at Reagan National Airport, 1999 Salon E & D, Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Ken D. Nakamura, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, 301–402–0838, nakamurk@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: February 2, 2016. Lawrence A. Tabak, Deputy Director, National Institutes of Health. Dated: February 4, 2016. Sylvia Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–02554 Filed 2–8–16; 8:45 am] [FR Doc. 2016–02538 Filed 2–8–16; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P VerDate Sep<11>2014 17:54 Feb 08, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on September 2, 2015, Vol. 80, No. 170, on page 53164. No comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institute of Drug Abuse (NIDA), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to Omb: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, or request more information on the proposed program, contact: Albert Avila, Ph.D., Director, Office of Diversity and Health Disparities, NIDA, NIH, 6001 Executive Blvd., Room 3106, Rockville, MD 20852, or call non-toll-free number (301)–443– 0441 or Email your request, including your address to: aavila@nida.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: NIDA Summer Research Internship Program 0925Existing Collection in Use Without an OMB Control Number, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). SUMMARY: E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 81, Number 26 (Tuesday, February 9, 2016)]
[Notices]
[Pages 6873-6874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02554]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The Use of Chimpanzees in NIH-Supported Research

SUMMARY: This notice provides information on the National Institutes of 
Health's (NIH) reassessment of the need to maintain a colony of 50 
chimpanzees for future research and decision to no longer maintain a 
chimpanzee colony for research. This notice also provides information 
on conforming updates and procedures related to this action.

FOR FURTHER INFORMATION CONTACT: The Division of Program Coordination, 
Planning, and Strategic Initiatives, Office of the Director, National 
Institutes of Health at dpcpsi@od.nih.gov.

SUPPLEMENTARY INFORMATION: On November 18, 2015, the NIH announced it 
will no longer maintain a colony of 50 chimpanzees for future research 
and that all NIH-owned chimpanzees that reside outside the federal 
sanctuary system operated by Chimp Haven, Keithville, Louisiana, are 
eligible for retirement. Relocation of the chimpanzees to the federal 
sanctuary system will be conducted as space is available and on a 
timescale that will allow for optimal transition of each individual 
chimpanzee with careful consideration of their welfare, including their 
health and social grouping. See the NIH Director's statement at https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-will-no-longer-support-biomedical-research-chimpanzees. Consistent with this 
decision, the NIH is limiting its future support for research using 
chimpanzees to that which would be permissible in the federal sanctuary 
system under the Chimpanzee Health Improvement, Maintenance and 
Protection (CHIMP) Act and the implementing regulations at 42 CFR part 
9. Such research must either be noninvasive behavioral studies or 
medical studies based on information collected during the course of 
normal veterinary care that is provided for the benefit of the 
chimpanzee, provided that any such study involves minimal physical and 
mental harm, pain, distress, and disturbance to the

[[Page 6874]]

chimpanzee and the social group in which the chimpanzee lives.
    Specifically, permissible research, as described in the ``Standards 
of Care for Chimpanzees Held in the Federally Supported Chimpanzee 
Sanctuary System'' at 42 CFR part 9, includes:
     Visual observation;
     Behavioral studies designed to improve the establishment 
and maintenance of social groups. These activities may cause stress as 
a result of novel interactions between chimpanzees and caregivers, but 
they are not considered invasive as long as they are intended to 
maximize the well-being of the chimpanzees;
     Medical examinations as deemed necessary to oversee the 
health of the chimpanzees, in the least invasive manner possible. 
Collection of samples routinely obtained during a physical examination 
for processing during this time is also considered noninvasive since a 
separate event is not required;
     Administration and evaluation of environmental enrichment 
used to promote the psychological well-being of the chimpanzees; and
     Actions taken to provide essential medical treatment to an 
individual chimpanzee exhibiting symptoms of illness. This applies only 
to serious illness that cannot be treated while the chimpanzee remains 
within the colony.
     Observational studies and collection of biomaterial in the 
wild without interfering with the chimpanzee is also permitted.
    These decisions apply to all new or competing renewals of grant 
applications, contract proposals, intramural protocols, and 3rd party 
projects. The NIH may issue future guidance about the permissible 
noninvasive research involving chimpanzees. Researchers are encouraged 
to contact their program officers for additional information or the 
Division of Program Coordination, Planning, and Strategic Initiatives 
at dpcpsi@od.nih.gov.
    The NIH's decision to allow the support of noninvasive research 
involving the use of chimpanzees, as described in this notice, does not 
affect requirements for investigators and/or their institutions to 
obtain permits from the U.S. Fish and Wildlife Service, if applicable, 
nor does it affect the responsibility to meet all applicable 
veterinary, colony, and husbandry obligations.

    Dated: February 2, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016-02554 Filed 2-8-16; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.